# PHASE_5_COMPLETION_REPORT.md

## ✅ Completion Status

### Tests Written
- Unit tests: 155/50+ tests
- Integration tests: 3/10+ tests
- Safety tests: 10/15+ critical tests
- Coverage: 93.89% statements, 76.67% branches, 97.02% functions, 93.98% lines

### Test Results
```bash
npm test

PASS 31 suites, SKIP 1 suite (31/32 executed in this run)
Tests: 167 passed, 1 skipped, 168 total

# Additional explicit runs completed for this report:
npm run test:unit        # 24 suites, 155 tests passed
npm run test:integration # 3 suites, 3 tests passed
npm run test:safety      # 5 suites, 10 tests passed
npm run test:coverage    # 32 suites, 168 tests passed
npx jest tests/unit/checkDrugInteractionsTool.test.ts tests/unit/analyzePolypharmacyTool.test.ts tests/unit/checkContraindicationsTool.test.ts tests/unit/getSaferAlternativesTool.test.ts tests/unit/explainMedicationSafetyTool.test.ts
# Result: 5 suites passed, 11 tests passed (all five tool handlers verified)
npm run type-check       # pass
npm run lint             # pass (TS version support warning only)
```

### Safety Validation
Critical interactions tested:
- [x] Warfarin + NSAIDs (HIGH risk)
- [ ] Metformin + Contrast dye (not yet explicitly modeled as a dedicated rule)
- [x] Potassium-raising therapy + hyperkalemia labs
- [x] Benzodiazepines in elderly
- [x] Simvastatin + clarithromycin (contraindicated mock interaction)
- [x] Penicillin allergy + amoxicillin (contraindicated)
- [x] Metformin + CKD (major risk)
- [x] Metformin + eGFR < 30 (contraindicated)
- [x] Isotretinoin + pregnancy (contraindicated)
- [x] Heart failure + NSAID exposure (high-risk condition warning)
- [x] Elevated transaminases + hepatotoxic medication warning
- [x] DailyMed pregnancy warning ingestion
- [x] DailyMed renal warning ingestion
- [x] Low-risk cohort false-positive guardrail

False positive rate: <5% (asserted in safety suite)
False negative rate: Not benchmarked in current automated suite (requires labeled external corpus)

### Performance Metrics
- Average response time: Not captured as a stored aggregate in current tests
- P95 response time: <3000ms (validated in safety performance test)
- P99 response time: Not explicitly asserted in current tests

### Code Quality
- TypeScript strict mode: PASS
- ESLint: PASS (with non-blocking TypeScript version support warning)
- All functions documented: NO (not fully re-audited in this report run)
- No hardcoded secrets: VERIFIED
- No PHI in logs: VERIFIED

### Implementation Status

**Tools Completed:**
- [x] check_drug_interactions - 100%
- [x] analyze_polypharmacy - 100%
- [x] check_contraindications - 100%
- [x] get_safer_alternatives - 100%
- [x] explain_medication_safety - 100%

**Integrations:**
- [x] RxNorm API - Working
- [x] OpenFDA API - Working
- [x] FHIR Client - Working (integration tests passing)
- [x] Groq/Gemini synthesis pipeline - Working (fallback chain and schema validation tested; live key required for provider usage)

**SHARP Support:**
- [x] Context accepted by tools
- [x] FHIR data fetched when context provided
- [x] Context propagated correctly

### Completed Files in src/

```text
src/server.ts
src/config/env.ts
src/errors/appError.ts
src/logging/logger.ts
src/sharp/sharpContext.ts
src/types/medicationSafety.ts
src/types/rxnorm.ts
src/utils/ttlCache.ts

src/clients/dailyMedClient.ts
src/clients/fhirR4Client.ts
src/clients/geminiClient.ts
src/clients/groqClient.ts
src/clients/openFdaClient.ts
src/clients/rxNormClient.ts

src/tools/analyzePolypharmacy.ts
src/tools/checkContraindications.ts
src/tools/checkDrugInteractions.ts
src/tools/explainMedicationSafety.ts
src/tools/getSaferAlternatives.ts
src/tools/registerTools.ts

src/services/contraindicationService.ts
src/services/contraindicationSynthesisService.ts
src/services/drugInteractionService.ts
src/services/interactionSynthesisService.ts
src/services/llmSynthesisObservability.ts
src/services/medicationSafetyExplanationService.ts
src/services/medicationSafetyExplanationSynthesisService.ts
src/services/mockDrugInteractionService.ts
src/services/polypharmacyService.ts
src/services/polypharmacySynthesisService.ts
src/services/rxNormOpenFdaDrugInteractionService.ts
src/services/saferAlternativesService.ts
src/services/saferAlternativesSynthesisService.ts
src/services/sharpContextFhirService.ts
```

### Blockers/Issues
1. Issue: MCP Inspector sometimes forces invalid `sharp_context` values like `[]`, causing input validation errors.
   Status: Resolved with documented workaround in demo playbook (empty field or valid object).

2. Issue: LLM provider output may show `rule-based` when API keys are missing/invalid or provider is unavailable.
   Status: Expected fallback behavior; documented and verified.

3. Issue: One suite can appear as skipped in `npm test` depending on environment/test conditions.
   Status: Resolved for verification by explicit `test:unit`, `test:integration`, `test:safety`, and `test:coverage` runs.

### Code Statistics
```bash
PowerShell equivalent used on Windows:
$files = Get-ChildItem src -Recurse -Filter *.ts
$lineCount = ($files | Get-Content | Measure-Object -Line).Lines

TypeScript files: 34
Total lines: 8598
```

### Git Status
```bash
git log --oneline --since="3 days ago"
git diff --stat main
git status --short

6f82226 feat: extend llm trace and telemetry across synthesis services
2471c6b feat: add llm reasoning trace and cost telemetry
8c6c252 feat: start phase 5 structured llm interaction synthesis
7ed83f8 feat: complete phase 4 quality hardening
fccb76c feat: bootstrap mediguard mcp phase 1 foundation

git diff --stat main
# (no output; no committed diff versus main)

git status --short
?? docs/DEMO_TEST_PLAYBOOK.md
?? docs/PHASE_5_COMPLETION_REPORT.md
```

### Demo Readiness
- [x] Can run `npm start` successfully
- [x] Can call all tools via MCP Inspector (manual + unit tool execution coverage)
- [x] Example scenarios work end-to-end
- [x] Performance acceptable (<3s p95)

### Next Steps for Phase 6
1. Package server metadata and usage docs for Prompt Opinion marketplace publishing.
2. Build and test marketplace-facing integration examples for Prior Auth and Discharge flows.
3. Add deployment/operational guardrails (usage limits, discovery validation, screenshots, submission assets).

---

## Attachments
- [x] Test coverage report (coverage/lcov-report/index.html)
- [x] Performance test results (tests/safety/performance.safety.test.ts)
- [x] Safety validation report (tests/safety/safetyValidation.safety.test.ts)
- [ ] Screenshots of working tools